CHARACTERIZE THE IMMUNE-ONCOLOGIC PROFILE OF LETHAL PROSTATE CANCER IN AFRICAN AMERICAN MEN AND DEVELOP NEW THERAPEUTIC AVENUES FOR THIS PATIENT POPULATION
$1,651,794FY2019Defense Health AgencyDOD
H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc.